 MARIETTA, Ga., March 30, 2021 GLOBE NEWSWIRE -- MiMedx Group, Inc. Nasdaq: MDXG MiMedx or the Company, an industry leader in utilizing birth tissue as a platform for regenerative medicine, today announced that the Company has been awarded a Group Purchasing Agreement for its amniotic tissue portfolio with Premier Inc.s Synergizing for Unparalleled Results in Procurement and Strategic Sourcing SURPASS purchasing program. Effective April 1, 2021, the new Regenerative Skin Grafting Products agreement allows SURPASS members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the MiMedxs placental-based tissue advanced wound care products. 